Press Releases
DMC Biotech Total Series A Fundraising Closes With $11.3 Million
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
Patent Allowed for DMC’s Dynamic Metabolic Control Technology
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
National Science Foundation Awards Additional $500,000 to DMC Biotechnologies, Inc. For Commercialization Through the NSF SBIR Phase IIB Program
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
DMC Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…